A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.
a Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA.
Eric
E
Gars
b Department of Clinical Pathology, Faculty of Medicine , Kasr El-Ainy Hospital, Cairo University , Cairo , Egypt.
Sherif M
SM
Yousry
c Department of Pathology , University of New Mexico, University of New Mexico , Albuquerque , NM , USA.
Daniel
D
Babu
a Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA.
Jason H
JH
Kurzer
c Department of Pathology , University of New Mexico, University of New Mexico , Albuquerque , NM , USA.
Tracy I
TI
George
a Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA.
Dita
D
Gratzinger
D000068816:Adapalene / Q000378:metabolism*; D015415:Biomarkers; D001853:Bone Marrow / Q000473:pathology; D002452:Cell Count; D060833:Cellular Microenvironment; D006801:Humans; D007150:Immunohistochemistry; D059630:Mesenchymal Stem Cells / Q000378:metabolism* / Q000473:pathology*; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000378:metabolism* / Q000473:pathology; D011379:Prognosis
D015415:Biomarkers; D000068816:Adapalene